The industry’s hopes that a US federal spending bill would reduce the impact of the Food and Drug Administration’s (FDA’s) deeming regulations were disappointed this week when a Senate committee approved a version that makes no reference to tobacco products. Passed unanimously by the Senate Appropriations Committee, the measure remained silent not only on e-cigarettes but on tobacco products in general. ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section